Colgate-Palmolive (NYSE:CL – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the twenty-two analysts that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have assigned a buy rating to the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $103.63.
CL has been the subject of several research reports. StockNews.com lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Stifel Nicolaus lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and reduced their price objective for the company from $105.00 to $101.00 in a research report on Monday, October 28th. JPMorgan Chase & Co. boosted their target price on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. Piper Sandler reduced their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. Finally, TD Cowen decreased their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th.
View Our Latest Report on Colgate-Palmolive
Colgate-Palmolive Price Performance
Colgate-Palmolive Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be given a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.28%. Colgate-Palmolive’s dividend payout ratio is currently 57.31%.
Insider Activity at Colgate-Palmolive
In related news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.34% of the stock is owned by corporate insiders.
Institutional Trading of Colgate-Palmolive
Several large investors have recently bought and sold shares of the company. D Orazio & Associates Inc. grew its position in shares of Colgate-Palmolive by 3.9% in the 3rd quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock worth $297,000 after buying an additional 108 shares during the period. Fiducient Advisors LLC grew its holdings in Colgate-Palmolive by 5.2% in the third quarter. Fiducient Advisors LLC now owns 2,231 shares of the company’s stock worth $232,000 after purchasing an additional 110 shares during the period. Wealthspire Advisors LLC increased its stake in shares of Colgate-Palmolive by 3.0% during the second quarter. Wealthspire Advisors LLC now owns 3,853 shares of the company’s stock valued at $374,000 after purchasing an additional 111 shares in the last quarter. Sequoia Financial Advisors LLC lifted its holdings in shares of Colgate-Palmolive by 0.6% during the third quarter. Sequoia Financial Advisors LLC now owns 20,392 shares of the company’s stock valued at $2,117,000 after purchasing an additional 113 shares during the last quarter. Finally, Great Waters Wealth Management boosted its position in shares of Colgate-Palmolive by 1.5% in the 3rd quarter. Great Waters Wealth Management now owns 7,669 shares of the company’s stock worth $796,000 after purchasing an additional 117 shares in the last quarter. 80.41% of the stock is owned by institutional investors.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
- Five stocks we like better than Colgate-Palmolive
- What is a Special Dividend?
- The Fed Is More Likely to Hike Than Cut Rates in 2025
- Differences Between Momentum Investing and Long Term Investing
- Investors Navigate Uncertainty by Seeking Refuge in Gold and Oil
- Which Wall Street Analysts are the Most Accurate?
- Archer Aviation Shares Slide, Now Bargain Priced for 2025
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.